About
Epigentek is the leading developer and provider of innovative technologies and products for epigenetic-related research. Founded in 2005, the company has since developed a comprehensive portfolio of proprietary products to provide complete and systematic solutions for epigenetics-related research and drug discovery. Epigentek products are used all around the world by esteemed academic institutions, leading pharmaceuticals, and cutting-edge biotechnology companies. These unique products are specifically designed to make assays much simpler, faster, more convenient, and highly more efficient than currently used methods. Epigentek's products are sold through a dedicated sales force and a global network of distributors in more than thirty six countries and regions. The company, particularly emphasizing speed and cost-effectiveness in its technologies, continues to focus on epigenetic innovation and extensively develop and enhance its product portfolio.
Position in the VCSift Database
- • 3,884 investors in VCSift focus on the healthtech sector.
- • 2 investors are based in Farmingdale, New York, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Sectors
- healthtech biotech
- Location
- Farmingdale, US
Contact Information
Find more investors like Epigentek
Search Investors